The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1

  • Lisa Derosa, Bertrand Routy, Guido Kroemer, Laurence Zitvogel
  • OncoImmunology, April 2018, Taylor & Francis
  • DOI: 10.1080/2162402x.2018.1434468

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/2162402x.2018.1434468